Mankind Pharma (BOM:543904) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Mankind Pharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Mankind Pharma's Free Cash Flow for the three months ended in Dec. 2023 was ₹0 Mil. Mankind Pharma's Revenue for the three months ended in Dec. 2023 was ₹26,070 Mil. Therefore, Mankind Pharma's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Mankind Pharma's current FCF Yield % is -1.59%.

The historical rank and industry rank for Mankind Pharma's FCF Margin % or its related term are showing as below:

BOM:543904' s FCF Margin % Range Over the Past 10 Years
Min: -18.32 Med: 13.27 Max: 14.35
Current: -18.06

During the past 3 years, the highest FCF Margin % of Mankind Pharma was 14.35%. The lowest was -18.32%. And the median was 13.27%.

BOM:543904's FCF Margin % is ranked worse than
75.02% of 1029 companies
in the Drug Manufacturers industry
Industry Median: -0.47 vs BOM:543904: -18.06

Mankind Pharma FCF Margin % Historical Data

The historical data trend for Mankind Pharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mankind Pharma FCF Margin % Chart

Mankind Pharma Annual Data

Trend

Mar20

Mar21

Mar22

FCF Margin %

14.35

13.27

-18.32

Mankind Pharma Quarterly Data
	Mar20	Mar21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Mankind Pharma's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Mankind Pharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mankind Pharma's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mankind Pharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Mankind Pharma's FCF Margin % falls into.

Mankind Pharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Mankind Pharma's FCF Margin for the fiscal year that ended in Mar. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2022 )	/	Revenue (A: Mar. 2022 )
	=	-14257.47	/	77815.55
	=	-18.32 %

Mankind Pharma's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	26069.589
	=	0.00 %

Mankind Pharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Mankind Pharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mankind Pharma (BOM:543904) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mankind Pharma Ltd (BOM:543904) » Definitions » FCF Margin %

Traded in Other Exchanges

MANKIND:India

Address

262, Okhla Industrial Estate, Phase-III, New Delhi, IND, 110020

Website

https://www.mankindpharma.com

Mankind Pharma Ltd is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It operates at the intersection of Indian pharmaceutical formulations and consumer healthcare sectors with the aim of providing quality products at affordable prices and has an established track record of building and scaling brands in-house. The company's brands include Manforce, Prega News and Gas-O-Fast.

Mankind Pharma (BOM:543904) Headlines

No Headlines